Genetics in the era of targeted CLL therapy

Blood. 2020 Jun 25;135(26):2333-2334. doi: 10.1182/blood.2020005595.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • Bridged Bicyclo Compounds, Heterocyclic
  • Genetic Markers
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell* / drug therapy
  • Leukemia, Lymphocytic, Chronic, B-Cell* / genetics
  • Prognosis
  • Sulfonamides

Substances

  • Antibodies, Monoclonal, Humanized
  • Bridged Bicyclo Compounds, Heterocyclic
  • Genetic Markers
  • Sulfonamides
  • venetoclax
  • obinutuzumab